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SUMMARY
Dogs infected withAngiostrongylus vasorum, a potentially lethal parasite parasitizing the heart and pulmonary arteries, may
present severe respiratory, haematological and neurological signs. In this ﬁrst large-scale seroepidemiological survey, 4003
sera originating from Germany and 4030 from the UK were tested by an ELISA for the detection of circulating antigen of
A. vasorum, and by a separate ELISA detecting speciﬁc antibodies. In Germany, where mainly western federal states were
sampled, 0·3% (n= 13, CI: 0·2–0·6%) of dogs were positive in both ELISAs, whereas in total 0·5% (n= 20, CI: 0·3–0·8%)
were antigen-positive and 2·25% (n= 90, CI: 1·8–2·8%) were positive for speciﬁc antibodies. Regions with antigen- and
antibody-positive animals were overlapping. In theUK, wheremainly the south of the country was sampled, 0·97% (n= 39,
CI: 0·7–1·3%) of dogs were antigen- and antibody positive. In total, 1·32% (n= 53, CI: 1·0–1·7%) were antigen-positive, and
3·2% (n= 129, CI: 2·7–3·8%) were positive for speciﬁc antibodies, again in overlapping regions. These results conﬁrm the
occurrence of A. vasorum in a random dog population originating from large parts of the countries investigated. The use of
the tests alone or in combination was considered as a function of their sensitivities and speciﬁcities, in order to guide eﬃcient
clinical and epidemiological application.
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INTRODUCTION
Angiostrongylus vasorum is a nematode parasite of the
right heart and pulmonary arteries of dogs and foxes,
and uses Gastropoda as intermediate hosts (Guilhon,
1963; Rosen et al. 1970). The parasite was ﬁrst
described in France in the 19th century (Serres,
1854), followed by reports of endemic foci in south-
western France (Cuillé andDarraspen, 1930), Ireland
(Roche and Kelliher, 1968), Switzerland (Wolﬀ et al.
1969), England (Jacobs and Prole, 1975) and Italy
(Poli et al. 1984). During recent decades, A. vasorum
has increasingly been reported in extended areas in
central and western European countries and also in
Canada (Conboy, 2004) in dogs and wild carnivores.
In Germany, single case reports (Barutzki and
Schaper, 2003; Staebler et al. 2005; Denk et al.
2009) as well as epidemiological studies (Taubert
et al. 2008; Barutzki and Schaper, 2009) have
been performed based on canine fecal analyses.
Angiostrongylus vasorum was described mainly in
south-western regions. In the UK the presence of
A. vasorum was originally described to be restricted
to southern parts of the country (southern England,
Wales) (Simpson and Neal, 1982; Chapman et al.
2004). Angiostrongylus vasorum has also long been
present in the Republic of Ireland (Roche and
Kelliher, 1968; Gallagher et al. 2012). A post-
mortem survey of foxes, the main wild reservoir of
the parasite, suggested northward spread within the
UK (Morgan et al. 2008), as conﬁrmed by recent
reports of cases in dogs from northern parts of the
UK, including Scotland (Hayes and Rowlands, 2004;
Helm et al. 2009; Yamakawa et al. 2009).
Infected dogs classically present with respiratory
symptoms but clinical signs may be highly variable
(Koch and Willesen, 2009; Schnyder et al. 2010),
making the diagnosis of A. vasorum infections
particularly challenging. Due to the often chronic
and subtle course of the infection, owners often
become aware only when severe symptoms such as
coagulopathies or neurological disorders (Wessmann
et al. 2006; Gredal et al. 2011) have established, with
frequently fatal outcome (Staebler et al. 2005;
Traversa et al. 2008; Denk et al. 2009; Yamakawa
et al. 2009). Therefore, knowledge of the epidemi-
ological situation concerning the presence of
A. vasorum is fundamental for both animal owners
and practising veterinarians. In known endemic
areas, prevention of clinical angiostrongylosis is
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recommended through monthly use of macrocyclic
lactones (Schnyder et al. 2009) or routine screening of
dogs for A. vasorum infection (Verzberger-Epshtein
et al. 2008; Schnyder et al. 2011).
Currently, diagnosis of A. vasorum infections is
mainly based on the detection of ﬁrst-stage larvae
(L1) in fecal samples by larval migration methods
such as the Baermann technique (Deplazes et al.
2012). Patency is described to start after 38–57 days
post infection (dpi) (Bolt et al. 1994; Schnyder et al.
2010), when damage to the lung parenchyma is
already present (Guilhon and Cens, 1969; Neﬀ,
1971). Intermittent larval excretion has been de-
scribed (Oliveira-Junior et al. 2006) and, therefore,
repeated testing of fecal samples is suggested, in order
to increase diagnostic sensitivity. Alternative diag-
nostic tools such as molecular methods (Jeﬀeries et al.
2009; Al-Sabi et al. 2010) or highly speciﬁc sero-
logical tests have been developed (Schnyder et al.
2011; Schucan et al. 2012). ELISAs (Enzyme-linked
immunosorbent assays) represent a valid and aﬀord-
able tool for diagnosis in both individual and
population studies, and have been very recently
validated for A. vasorum infection in a ﬁeld study
(Guardone et al. 2013).
The objective of this research was to perform a
sero-epidemiological survey of circulating antigens
of A. vasorum and of speciﬁc antibodies against
A. vasorum in sera of dogs originating fromGermany
and the UK. In addition, independent estimates of
test sensitivities and speciﬁcities were used in the
context of observed prevalence in this study to
consider how each test might be eﬃciently used
alone or in combination to support clinical and
epidemiological investigations.
MATERIALS AND METHODS
Sera of 4003 dogs from Germany and 4030 dogs
from the UK were submitted to private veterinary
diagnostic laboratories (Vet Med Labor GmbH,
Idexx Laboratories, Ludwigsburg in Germany, and
Idexx Laboratories Ltd, Southwater and Idexx
Laboratories Ltd, Wetherby in the UK) for various
medical reasons. Samples from Germany originated
from western federal states and northern Bavaria,
while samples from the UK were obtained from
widespread areas of England and Wales, with a
concentration in the south-east.
All samples were stored at −20 °C before and
after sending them to the Institute of Parasitology in
Zurich, where they were analysed for the presence of
circulating A. vasorum antigens in a sandwich-
ELISA using mono- and polyclonal antibodies
(sensitivity 95·7%, speciﬁcity 94·0%), as previously
described (Schnyder et al. 2011). Additionally, an
ELISA detecting speciﬁc antibodies using excretory/
secretory (E/S) antigens of adult stages (sensitivity
85·7%, speciﬁcity 98·8%) was used (Schucan et al.
2012). Test thresholds were regionally determined
with 300 randomly selected samples based on the
mean value of optical density (A405 nm) plus 3
(antigen detection) or 4 (antibody detection) standard
deviations (S.D.).
The collected data were analysed by a geographic
information system (GIS) using the program
RegioGraph 10 (GfK GeoMarketing, Bruchsal,
Germany) to visualize the regional distribution of
collected and analysed serum samples andA. vasorum
antigen and/or antibody positive samples. Based on
the four digit (UK) and ﬁve-digit postcodes
(Germany) as points of reference, the locations of
positive samples were displayed on maps with
administrative and postcode boundaries. Due to
privacy protection, no further data concerning the
animal or the animal owner were available. Excel
2007 for Windows (Microsoft Corporation,
Redmond, USA) was used to calculate the prevalence
values, the conﬁdence interval (CI) of the sensitivities
and the speciﬁcities and for the calculation of means
and S.D.
The sensitivity (SE) and speciﬁcity (SP) of
combined tests were calculated from those of
individual tests (denoted by suﬃx a or b) using the
method described by Weinstein et al. (2005). Thus,
test results can be combined using the OR rule, i.e.
the combined test is positive if either individual test
returns a positive result, and negative only if both
individual tests are negative. Alternatively, using
the AND rule, the combined test is positive only
if both individual tests are positive, and negative
if either individual test is negative. Using the OR
rule, combined SE = SEa+SEb− (SEa×SEb), and
combined SP = (SPa×SPb). Using the AND rule,
combined SE = (SEa×SEb), and combined SP =
SPa+SPb− (SPa×SPb). Positive predictive value
(PPV), which depends also on the population pre-
valence of infection (prev), was calculated as: PPV =
(SE×prev)/((SE×prev)+(1−SP)(1−prev)).
RESULTS
The location and seropositivity of all tested samples
in Germany, where mainly western federal states
were sampled, is shown in Fig. 1. A total of 0·3%
(n = 13, conﬁdence intervals, CI: 0·2–0·6%) of the
animals were positive in both ELISAs, while 0·5%
(n = 20, CI: 0·3–0·8%) of the tested dogs were
antigen-positive and 2·25% (n = 90, CI: 1·8–2·8%)
were positive for speciﬁc antibodies. Regions with
antigen- and antibody-positive animals were over-
lapping and distributed through the whole western
sampling area of the country.
The location and results of serological analysis of
sera from the UK, where mainly the south of the
country was sampled, are shown in Fig. 2A (UK) and
2B (southern England and Wales, with enlargement
of the area around London for details). A total of
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Fig. 1. Serological results of 4003 sera collected from western federal states in Germany, tested for the presence of
circulating Angiostrongylus vasorum antigens (Schnyder et al. 2011) and for the presence of A. vasorum speciﬁc
antibodies (Schucan et al. 2012). Test thresholds were regionally determined with 300 randomly selected samples based
on the mean value of optical density (A405 nm) plus 3 (antigen detection) or 4 (antibody detection) standard deviations.
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0·97% (n = 39, CI: 0·7–1·3%) of the dogs were
antigen- and antibody positive. Overall, 1·32%
(n = 53, CI: 1·0–1·7%) of the animals were antigen-
positive, and 3·2% (n= 129, CI: 2·7–3·8%) were
positive for speciﬁc antibodies, again in overlapping
regions.
The eﬀect of combining antigen and antibody
detection tests is summarized in Table 1, where it has
to be considered that antigen detection represents an
actual infection, while speciﬁc Ab detection rep-
resents a parasite exposure. When using the OR rule,
since the combined test is deemed positive if either
individual test yields a positive result, overall
sensitivity is enhanced, but at the cost of decreased
overall speciﬁcity. Conversely, using the AND rule,
both tests must be positive to return a combined
positive result and, as this is harder to achieve,
speciﬁcity is higher than that of either individual
test, but sensitivity is lower. Variation in the PPV
of diﬀerent tests and combinations with changing
population prevalence of infection withA. vasorum is
shown in Fig. 3.
DISCUSSION
Results conﬁrmed the endemic presence of
A. vasorum in Germany as well as in the UK, and
additionally cases outside the known endemic foci
were detected. The use of ELISA techniques allowed
for the ﬁrst time a large sero-epidemiological survey
in these two countries. Thus, this is the largest survey
of this emerging parasite so far conducted, and the
ﬁrst to report rates of infection in dogs in multiple
endemic countries using the same tests. Moreover, it
introduces the concept of using both antigen and
antibody detection ELISAs for epidemiological and
clinical diagnosis, oﬀering great potential for future
research and application. Sensitivity and speciﬁcity
of both tests had been previously assessed (Schnyder
et al. 2011; Schucan et al. 2012) and both tests had
been validated in a ﬁeld study in which serological
results were compared with results of Baermann
analyses (Guardone et al. 2013). ELISAs were shown
to be robust, giving coherent results, i.e. with
haemolytic or lipaemic sera or when thawed and
frozen several times. Baermann techniques with
isolation of L1 are routinely applied for diagnosis of
lungworms, with limitations concerning sensitivity
(as a consequence of irregular larval shedding, the
diﬃculties of collecting multiple fecal samples and of
guaranteeing proper storage of the samples before
analysis) and also speciﬁcity, if not performed by
experienced technicians. ELISAs were shown to
positively conﬁrm samples from Baermann-positive
dogs, and additionally detected non-patent infections
(Guardone et al. 2013), and are therefore highly
sensitive methods. However, interpretation of the
two ELISA tests diﬀers: while speciﬁc antibody
detection is useful for the determination of parasite
exposure, antigen detection represents an actual
infection. This explains the higher number of
positive dogs using antibody detection compared
with antigen detection (90/20 and 129/53 for
Germany and the UK, respectively). Implications
of positive results with each or both individual tests
go beyond those of manipulating overall sensitivity
and speciﬁcity. Thus, dogs positive for both tests, in
which circulating antigens as well as speciﬁc anti-
bodies against A. vasorum are detected, can be
assumed to harbour an active A. vasorum infection
inducing an immunological reaction with production
of antibodies. Dogs in which only antibodies are
detected may have acquired A. vasorum recently,
since antibodies can already be detected 21 dpi, while
antigen is ﬁrst detected 35 dpi (Schnyder et al. 2011;
Schucan et al. 2012). Alternatively, antibody-positive
dogs may be parasite-free, i.e. after eﬃcacious
anthelmintic treatment or natural clearance of infec-
tion: dogs become seronegative for antigen detection
within 16–34 days after single treatment with
imidacloprid/moxidectin (Advocate® spot on)
(Schnyder et al. 2011), while antibodies persist up
to 63 days after treatment (Schucan et al. 2012).
Furthermore, cross-reactions and false positive re-
sults cannot be completely excluded, although the
indicated speciﬁcities, based on sera of dogs infected
with other common (Toxocara canis, Ancylostoma
caninum, Leishmania sp.) and uncommon (Diroﬁlaria
immitis, Diroﬁlaria repens, Crenosoma vulpis, Eucoleus
aerophilus) parasitic infections, are high (Schnyder
et al. 2011; Schucan et al. 2012).
While the performance of the tests, alone or in
combination, is predictable from their independently
estimated sensitivities and speciﬁcities, their PPV
depends also on population prevalence of infection.
This should inﬂuence the way in which the tests are
used in practice (Pepe and Thompson, 2000). Thus,
for instance, in a situation of surveillance for the early
appearance of angiostrongylosis in an area of low
Table 1. Sensitivity and speciﬁcity of the two
serological tests for detection of Angiostrongylus









Sensitivity 0·857 0·957 0·994 0·820
Speciﬁcity 0·988 0·940 0·929 0·999
Ab-ELISA= antibody detection, representing parasite
exposure; Ag-ELISA= antigen detection, representing an
actual infection; Ab OR Ag is positive if either individual
test is positive, and negative if both are negative; Ab AND
Ag is positive only if both individual tests are positive, and
negative if either is negative. Combining tests by the ‘OR’
rule enhances sensitivity at the cost of speciﬁcity, while the
‘AND’ rule enhances speciﬁcity but at the cost of
sensitivity.
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(A)
Fig. 2. See the following page for legend.
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(B)
Fig. 2. (A) Overview of the UK and the results of the seroepidemiological survey for canine angiostrongylosis;
(B) Serological results of 4030 sera collected from England and Wales. Results of dogs from London and surroundings
are additionally represented separately because of overlapping symbols. For details of test performance see Fig. 1.
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expected prevalence, if both tests are used together
and a positive result declared only if both individual
tests are positive, the PPV is substantially increased
and therefore the risk of false negatives decreased. By
contrast, clinical diagnosis in an area of known high
prevalence might eﬃciently use the more sensitive
antigen detection test ﬁrst, and perhaps conﬁrm
positives using the more speciﬁc antibody detection
test. When assessing the cost of misclassiﬁcation
error, it should be noted that treatment of false
positives is much less grave clinically than non-
treatment of false negative cases, since these could
succumb to severe and possibly fatal disease. The
information provided in Table 1 and Fig. 3 should
enable users to choose an appropriate strategy for
their purpose.
In epidemiological surveys, the trade-oﬀ between
sensitivity and speciﬁcity is further aﬀected by
sample size. Thus, decreased sensitivity (in favour
of increased speciﬁcity, e.g. using the AND rule) is
less likely to miss infection where it is really present if
sample size is large. The data presented here will
assist in the design and power analysis of such
surveys. As a result, increased information and
disease awareness will lead to more appropriate
testing. The combined use of antigen and antibody
detection ELISA oﬀers great potential for early and
sensitive diagnosis of these infections, which are
otherwise potentially lethal, mainly due to coagulo-
pathies and neurological problems in cases not
subjected to timely diagnosis (Staebler et al. 2005;
Traversa et al. 2008; Denk et al. 2009; Yamakawa
et al. 2009). Accordingly, adequate anthelmintic
treatments can be implemented. This is also essential
to prevent pathological changes, which can be present
in lungs early during infection (Neﬀ, 1971; Schnyder
et al. 2009; Dennler et al. 2011). Due to privacy
protection, no further information concerning the
tested animals was available, and no Baermann
analysis of fecal samples for conﬁrmation of sero-
logically positive samples was possible. Besides, it
was not possible to give feedback to veterinarians in
charge of serologically positive animals to encourage
their treatment.
The sero-prevalences obtained in this study among
dogs sampled for various diseases cannot be directly
compared with prevalence data obtained through
testing fecal samples of dogs with the Baermann
technique. Nevertheless, an evident overlapping of
the areas in Germany with positive dogs is observed:
in a recently published study, a prevalence of 7·4%
was detected in dogs originating from approximately
the same areas, selected for cardiorespiratory signs,
and tested with fecal samples collected over 3 days
(Barutzki and Schaper, 2009). In another study with
pre-selected dogs having clinical signs of potential
lungworm infections, prevalence tested with fecal
samples collected on a single day was 1·2% (Taubert
et al. 2008); these samples were collected from larger
parts of Germany, with positives also originating
mainly from western and southern areas of the
country. Sera in the present study were submitted
for miscellaneous but unknown medical reasons,
including cardiorespiratory signs; due to their high
number the dataset is considered representative of an
average canine population.
Previous population studies in dogs based on fecal
analyses in the UK, as previously reviewed (Morgan
et al. 2010), were restricted to areas of London in
stray/re-homed dogs (with a prevalence of 1·8%) and
Cornwall (Martin and Neal, 1992) in pre-selected
dogs showing compatible clinical signs (prevalence:
4·1%). A geographical summary of canine cases
from 2009 (Yamakawa et al. 2009) showed that
canine angiostrongylosis, once restricted to Wales
and southern England, is expanding to northern
England, with single case reports in that region
complemented by a single case reported from
Scotland (Helm et al. 2009). A questionnaire survey
sent to 3950 small animal practices during 2009
conﬁrmed that A. vasorum appears to be spreading
beyond the traditional endemic foci in the UK
(Ashley et al. 2012). This situation was anticipated
by a study on 546 foxes culled between 2005 and 2006
(Morgan et al. 2008). The detected prevalence in the
present study of up to 3·2% (antibody detection)
conﬁrms the presence of A. vasorum in non-selected
dogs from Wales and large parts of central and
southern England.
Fig. 3. Positive predictive value of the serological tests,
i.e. the proportion of positive test results that indicate a
truly positive sample. Ab = antibody-detection ELISA
(continuous curve); Ag = antigen-detection ELISA (large
dashed curve); AND= positive if both tests are positive
(short dashed curve), OR= positive if either test is
positive (dotted curve). Ag detection and the combined
antigen plus speciﬁc Ab detection represent actual
infections, while speciﬁc Ab detection represents a
parasite exposure. At low prevalence, tests with high
speciﬁcity have a particularly strong advantage in terms of
positive predictive value, in this case the combined AND
test. Positive predictive value generally trades oﬀ against
sensitivity (see Table 1).
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In conclusion, diagnostic testing with ELISAs
enables detection of infection with A. vasorum
shortly before or contemporaneously with patency,
requires a single serum sample instead of repeated
fecal samples, and has the potential for a rapid
diagnostic test, particularly in the case of a large
number of samples. The detection of circulating
antigens and speciﬁc antibodies against A. vasorum
by ELISA therefore represents a useful and reliable
tool for population studies as shown for large areas of
Germany and the UK. The combined use of antigen
and antibody detection ELISA oﬀers great potential
for future research and application for epidemiologi-
cal and clinical diagnosis. Increased knowledge
concerning the epidemiological situation and there-
fore disease awareness of this potentially fatal parasite
of dogs allows early diagnosis of the infection. This is
essential to ensure adequate treatments in case of
severe canine angiostrongylosis but also holds true for
dogs at early stages of infection, therefore avoiding
the onset of pathological changes, which are possible
even in the absence of clinical signs. Furthermore,
in known endemic areas prophylactic anthelmintic
treatment or routine screening of dogs forA. vasorum
infection are recommended. This is particularly
important considering the conﬁrmed establishment
and potential expansion of A. vasorum in various
European countries.
ACKNOWLEDGEMENTS
We are very grateful to Dr Iskanderali Ziadinov and
Isabelle Tanner from the Institute of Parasitology in Zurich
for their very valuable support and Carola Hafner and
David Fox for the organization of the samples.
FINANCIAL SUPPORT
This work was supported by Bayer AG.
REFERENCES
Al-Sabi, M.N., Deplazes, P., Webster, P., Willesen, J. L.,
Davidson, R. K. and Kapel, C.M. (2010). PCR detection of
Angiostrongylus vasorum in faecal samples of dogs and foxes. Parasitology
Research 107, 135–140. doi: 10.1007/s00436-010-1847-5.
Ashley, L., Limon, G., Guitian, J., Hermosilla, C. and Fox, M. T.
(2012). Angiostrongylus vasorum in the United Kingdom – a nationwide
postal questionnaire survey. In 2nd Bayer Angiostrongylosis Forum Including
Major Parasitic Lung Diseases of Dogs and Cats (ed. Schaper, R.), Parma,
Italy, 22nd June 2012.
Barutzki, D. and Schaper, R. (2003). Endoparasites in dogs and cats
in Germany 1999–2002. Parasitology Research 90(Suppl.), S148–S150.
doi: 10.1007/s00436-003-0922-6.
Barutzki, D. and Schaper, R. (2009). Natural infections ofAngiostrongylus
vasorum and Crenosoma vulpis in dogs in Germany (2007–2009).
Parasitology Research 105(Suppl.), S39–S48. doi: 10.1007/s00436-009-
1494-x.
Bolt, G., Monrad, J., Koch, J. and Jensen, A. L. (1994). Canine
angiostrongylosis: a review. Veterinary Record 135, 447–452.
Chapman, P. S., Boag, A. K., Guitian, J. and Boswood, A. (2004).
Angiostrongylus vasorum infection in 23 dogs (1999–2002). Journal of Small
Animal Practice 45, 435–440.
Conboy, G. (2004). Natural infections of Crenosoma vulpis and
Angiostrongylus vasorum in dogs in Atlantic Canada and their treatment
with milbemycin oxime. Veterinary Record 155, 16–18.
Cuillé, J. and Darraspen, E. (1930). De la Strongylose cardio-pulmonaire
du chien. Revue Générale de Médecine Vétérinaire 466, 625–639, 694–710.
Denk, D., Matiasek, K., Just, F. T., Hermanns, W., Baiker, K.,
Herbach, N., Steinberg, T. and Fischer, A. (2009). Disseminated
angiostrongylosis with fatal cerebral haemorrhages in two dogs in Germany:
a clinical case study. Veterinary Parasitology 160, 100–108. doi: 10.1016/
j.vetpar.2008.10.077.
Dennler, M., Makara, M., Kranjc, A., Schnyder, M., Ossent, P.,
Deplazes, P., Ohlerth, S. and Glaus, T.M. (2011). Thoracic computed
tomography ﬁndings in dogs experimentally infected with Angiostrongylus
vasorum. Veterinary Radiology and Ultrasound 52, 289–294. doi: 10.1111/
j.1740-8261.2010.01776.x.
Deplazes, P., Eckert, J., v. Samson-Himmelstjerna, G. and
Zahner, H. (2012). Lehrbuch der Parasitologie für die Tiermedizin. Enke
Verlag, Stuttgart, Germany.
Gallagher, B., Brennan, S. F., Zarelli, M. and Mooney, C. T.
(2012). Geographical, clinical, clinicopathological and radiographic features
of canine angiostrongylosis in Irish dogs: a retrospective study. Irish
Veterinary Journal 65, 5. doi: 10.1186/2046-0481-65-5.
Gredal, H., Willesen, J. L., Jensen, H. E., Nielsen, O. L.,
Kristensen, A. T., Koch, J., Kirk, R. K., Pors, S. E., Skerritt, G. C. and
Berendt, M. (2011). Acute neurological signs as the predominant clinical
manifestation in four dogs with Angiostrongylus vasorum infections in
Denmark. Acta Veterinaria Scandinavica 53, 43. doi: 10.1186/1751-0147-
53-43.
Guardone, L., Schnyder, M., Macchioni, F., Deplazes, P. and
Magi, M. (2013). Serological detection of circulating Angiostrongylus
vasorum antigen and speciﬁc antibodies in dogs from central and
northern Italy. Veterinary Parasitology 192, 192–198. doi: org/10.1016/
j.vetpar.2012.10.016.
Guilhon, J. (1963). Recherches sur le cycle évolutif du Strongle des
vaisseaux du chien. Bulletin de l’ Académie Vétérinaire 36, 431–442.
Guilhon, J. and Cens, B. (1969). Migrations and evolution of
Angiostrongylus vasorum (Baillet, 1866) in dogs. Comptes Rendus
Hebdomadaires des Seances de l’Academie des Sciences – D: Sciences
Naturelles 269, 2377–2380. (In French)
Hayes, G. and Rowlands, M. (2004).Angiostrongylus infection in a dog in
north-west England. Veterinary Record 154, 639.
Helm, J., Gilleard, J. S., Jackson, M., Redman, E. and Bell, R. (2009).
A case of canineAngiostrongylus vasorum in Scotland conﬁrmed by PCR and
sequence analysis. Journal of Small Animal Practice 50, 255–259. doi:
10.1111/j.1748-5827.2009.00741.x.
Jacobs, D. E. and Prole, J. H. (1975). Angiostrongylus vasorum and other
nematodes in British greyhounds. Veterinary Record 96, 180.
Jeﬀeries, R., Morgan, E. R. and Shaw, S. E. (2009). A SYBR green real-
time PCR assay for the detection of the nematodeAngiostrongylus vasorum in
deﬁnitive and intermediate hosts.Veterinary Parasitology 166, 112–118. doi:
10.1016/j.vetpar.2009.07.042.
Koch, J. and Willesen, J. L. (2009). Canine pulmonary angiostrongylosis:
an update.Veterinary Journal 179, 348–359. doi: 10.1016/j.tvjl.2007.11.014.
Martin, M. and Neal, C. (1992). Distribution of angiostrongylosis in
Cornwall. Journal of Small Animal Practice 33, 327–336.
Morgan, E. R., Tomlinson, A., Hunter, S., Nichols, T., Roberts, E.,
Fox, M. T. and Taylor, M. A. (2008). Angiostrongylus vasorum and
Eucoleus aerophilus in foxes (Vulpes vulpes) in Great Britain. Veterinary
Parasitology 154, 48–57. doi: 10.1016/j.vetpar.2008.02.030.
Morgan, E. R., Jeﬀeries, R., van Otterdijk, L., McEniry, R. B.,
Allen, F., Bakewell, M. and Shaw, S. E. (2010). Angiostrongylus vasorum
infection in dogs: presentation and risk factors.Veterinary Parasitology 173,
255–261. doi: 10.1016/j.vetpar.2010.06.037.
Neﬀ, H. (1971). Experimentelle Infektionen von Hunden mit
Angiostrongylus vasorum (Nematoda). Dissertation. Universität Zürich,
Zürich. (In German)
Oliveira-Junior, S. D., Barcante, J.M., Barcante, T. A., Dias, S. R. and
Lima, W. S. (2006). Larval output of infected and re-infected dogs with
Angiostrongylus vasorum (Baillet, 1866) Kamensky, 1905. Veterinary
Parasitology 141, 101–106. doi: 10.1016/j.vetpar.2006.05.003.
Pepe, M. S. and Thompson, M. L. (2000). Combining diagnostic test
results to increase accuracy. Biostatistics 1, 123–140. doi: 10.1093/
biostatistics/1.2.123.
Poli, A., Arispici,M.,Marconcini, A.,Mancianti, F. and deMonte, D.
(1984). Angiostrongylus vasorum (Baillet, 1866) in red foxes (Vulpes
vulpes L.) in Italy. Journal of Wildlife Diseases 20, 345–346.
Roche, M.M. and Kelliher, D. J. (1968). Angiostrongylus vasorum
infestation in the dog: a case report. Irish Veterinary Journal 22, 108–113.
1449Seroepidemiological survey for canine angiostrongylosis in Germany and the UK
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0031182013001091
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 13:23:56, subject to the Cambridge Core terms of use, available at
Rosen, L., Ash, L. R. and Wallace, G. D. (1970). Life history of the
canine lungworm Angiostrongylus vasorum (Baillet). American Journal of
Veterinary Research 31, 131–143.
Schnyder, M., Fahrion, A., Ossent, P., Kohler, L., Webster, P.,
Heine, J. and Deplazes, P. (2009). Larvicidal eﬀect of imidacloprid/
moxidectin spot-on solution in dogs experimentally inoculated
with Angiostrongylus vasorum. Veterinary Parasitology 166, 326–332.
doi: 10.1016/j.vetpar.2009.09.004.
Schnyder, M., Fahrion, A., Riond, B., Ossent, P., Webster, P.,
Kranjc, A., Glaus, T. and Deplazes, P. (2010). Clinical, laboratory and
pathological ﬁndings in dogs experimentally infected with Angiostrongylus
vasorum. Parasitology Research 107, 1471–1480. doi: 10.1007/s00436-010-
2021-9.
Schnyder, M., Tanner, I., Webster, P., Barutzki, D. and Deplazes, P.
(2011). An ELISA for sensitive and speciﬁc detection of circulating antigen
ofAngiostrongylus vasorum in serum samples of naturally and experimentally
infected dogs. Veterinary Parasitology 179, 152–158. doi: 10.1016/j.vetpar.
2011.01.054.
Schucan, A., Schnyder, M., Tanner, I., Barutzki, D., Traversa, D.
and Deplazes, P. (2012). Detection of speciﬁc antibodies in dogs infected
with Angiostrongylus vasorum. Veterinary Parasitology 185, 216–224.
doi: 10.1016/j.vetpar.2011.09.040.
Serres, E. (1854). Entozoaires trouvés dans l’oreille droite, le ventricule
correspondant et l’artère pulmonaire d’un chien. Journal des Vétérinaires du
Midi 7, 70. (In French)
Simpson, V. R. and Neal, C. (1982). Angiostrongylus vasorum infection in
dogs and slugs. Veterinary Record 111, 303–304.
Staebler, S., Ochs, H., Steﬀen, F., Naegeli, F., Borel, N., Sieber-
Ruckstuhl, N. and Deplazes, P. (2005). Autochthonous infections with
Angiostrongylus vasorum in dogs in Switzerland and Germany. Schweizer
Archiv fur Tierheilkunde 147, 121–127. (In German)
Taubert, A., Pantchev, N., Vrhovec, M. G., Bauer, C. and
Hermosilla, C. (2008). Lungworm infections (Angiostrongylus vasorum,
Crenosoma vulpis, Aelurostrongylus abstrusus) in dogs and cats in
Germany and Denmark in 2003–2007. Veterinary Parasitology 159,
175–180. doi: 10.1016/j.vetpar.2008.10.005.
Traversa, D., Torbidone, A., Malatesta, D. and Guglielmini, C.
(2008). Occurrence of fatal canine Angiostrongylus vasorum infection
in Italy. Veterinary Parasitology 152, 162–166. doi: 10.1016/j.vetpar.
2007.12.009.
Verzberger-Epshtein, I., Markham, R. J., Sheppard, J. A., Stryhn, H.,
Whitney, H. and Conboy, G. A. (2008). Serologic detection of
Angiostrongylus vasorum infection in dogs. Veterinary Parasitology 151,
53–60. doi: 10.1016/j.vetpar.2007.09.028.
Weinstein, S., Obuchowski, N. A. and Lieber, M. L. (2005).
Clinical evaluation of diagnostic tests. American Journal of Roentgenologists
184, 14–19.
Wessmann, A., Lu, D., Lamb, C. R., Smyth, B., Mantis, P.,
Chandler, K., Boag, A., Cherubini, G. B. and Cappello, R. (2006).
Brain and spinal cord haemorrhages associated withAngiostrongylus vasorum
infection in four dogs. Veterinary Record 158, 858–863.
Wolﬀ, K., Eckert, J. and Leemann, W. (1969). Beitrag zur
Angiostrongylose des Hundes. Dtsch Vet-med Ges, Zürich, Switzerland.
Yamakawa, Y., McGarry, J.W., Denk, D., Dukes-McEwan, J.,
Macdonald, N., Mas, A., McConnell, F., Tatton, B., Valentine, E. G.,
Wayne, J., Williams, J.M. and Hetzel, U. (2009). Emerging canine
angiostrongylosis in northern England: ﬁve fatal cases. Veterinary Record
164, 149–152.
1450M. Schnyder and others
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0031182013001091
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 13:23:56, subject to the Cambridge Core terms of use, available at
